These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9952193)

  • 1. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Kandzari DE; Goldschmidt-Clermont PJ
    JAMA; 1999 Feb; 281(5):415; author reply 417-9. PubMed ID: 9952193
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    McDiarmid TD; Hensel WA
    JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952195
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Krut LH
    JAMA; 1999 Feb; 281(5):414; author reply 417-9. PubMed ID: 9952192
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Haq IU; Wallis EJ; Yeo WW; Jackson PR; Ramsay LE
    JAMA; 1999 Feb; 281(5):414; author reply 417-9. PubMed ID: 9952191
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Walsh J
    JAMA; 1999 Feb; 281(5):416-7; author reply 417-9. PubMed ID: 9952197
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Papadakis JA; Mikhailidis DP
    JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952196
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Siegel D; Swislocki AL
    JAMA; 1999 Feb; 281(5):417-9. PubMed ID: 9952198
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Mason JM; Freemantle N
    JAMA; 1999 Feb; 281(5):415-6; author reply 417-9. PubMed ID: 9952194
    [No Abstract]   [Full Text] [Related]  

  • 9. [AFCAPS/TexCAPS [The Air Force/Texas Coronary Atherosclerosis Prevention Study]].
    Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():398-403. PubMed ID: 11347102
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM
    Am J Med; 1999 Aug; 107(2A):36S-39S. PubMed ID: 10484239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS.
    Sprecher DL
    Cleve Clin J Med; 2000 Mar; 67(3):169-71. PubMed ID: 10743305
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM
    Atheroscler Suppl; 2007 Aug; 8(2):3-8. PubMed ID: 17588826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women.
    Clearfield M; Downs JR; Weis S; Whitney EJ; Kruyer W; Shapiro DR; Stein EA; Langendorfer A; Beere PA; Gotto AM
    J Womens Health Gend Based Med; 2001 Dec; 10(10):971-81. PubMed ID: 11788107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of coronary heart disease: implications of the Air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS).
    Brown AS
    Curr Cardiol Rep; 2000 Sep; 2(5):439-44. PubMed ID: 10980912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Girman CJ; Rhodes T; Mercuri M; Pyörälä K; Kjekshus J; Pedersen TR; Beere PA; Gotto AM; Clearfield M;
    Am J Cardiol; 2004 Jan; 93(2):136-41. PubMed ID: 14715336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperlipidemia and arteriosclerosis].
    Mabuchi H
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):950-7. PubMed ID: 9648450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
    Ridker PM; Shih J; Cook TJ; Clearfield M; Downs JR; Pradhan AD; Weis SE; Gotto AM;
    Circulation; 2002 Apr; 105(15):1776-9. PubMed ID: 11956118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.
    Gotto AM; Boccuzzi SJ; Cook JR; Alexander CM; Roehm JB; Meyer GS; Clearfield M; Weis S; Whitney E
    Am J Cardiol; 2000 Dec; 86(11):1176-81. PubMed ID: 11090787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.